1. A new in vitro muscle contraction model and its application for analysis of mTORC1 signaling in combination with contraction and beta-hydroxy-beta-methylbutyrate administration
- Author
-
Nobuharu L. Fujii, Mitsuru Nomura, Ikko Yamana, Akira Uchiyama, Satoko Sato, Yasuko Manabe, and Yasuro Furuichi
- Subjects
0301 basic medicine ,030109 nutrition & dietetics ,Contraction (grammar) ,Myogenesis ,Metabolite ,Organic Chemistry ,Stimulation ,General Medicine ,mTORC1 ,Applied Microbiology and Biotechnology ,Biochemistry ,Analytical Chemistry ,Cell biology ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,chemistry ,medicine ,Phosphorylation ,medicine.symptom ,Molecular Biology ,Protein kinase B ,Biotechnology ,Muscle contraction - Abstract
Several food constituents augment exercise-induced muscle strength improvement; however, the detailed mechanism underlying these combined effects is unknown because of the lack of a cultured cell model for evaluating the contraction-induced muscle protein synthesis level. Here, we aimed to establish a new in vitro muscle contraction model for analyzing the activation of mammalian target of rapamycin complex 1 (mTORC1) signaling. We adopted the tetanic electric stimulation of 50 V at 100 Hz for 10 min in L6.C11 myotubes. Akt, ERK1/2, and p70S6K phosphorylation increased significantly after electrical pulse stimulation (EPS), compared to untreated cells. Next, we used this model to analyze mTORC1 signaling in combination with exercise and beta-hydroxy-beta-methylbutyrate (HMB), an l-leucine metabolite. p70S6K phosphorylation increased significantly in the EPS+HMB group compared to that in the EPS-alone group. These findings show that our model could be used to analyze mTORC1 signaling and that HMB enhances muscle contraction-activated mTORC1 signaling.
- Published
- 2019